Top In Vitro & In Vivo Diagnostic Substances Stocks by Roiver Score™
The 13 In Vitro & In Vivo Diagnostic Substances companies we cover, ranked by the Roiver Score — a transparent 0–100 quality composite. Idexx Laboratories Inc leads with a score of 66.
| # | Company | Market cap | Score |
|---|---|---|---|
| 1 | IDXXIdexx Laboratories Inc | $43.4B | 66Solid |
| 2 | LNTHLantheus Holdings, Inc | $6.6B | 53Solid |
| 3 | MYGNMyriad Genetics Inc | $607M | 25Mixed |
| 4 | TKNOAlpha Teknova, Inc. Common Stock | $454M | 20Weak |
| 5 | ICCCImmucell Corp | $93M | 20Weak |
| 6 | NEOGNeogen Corp | $2.6B | 19Weak |
| 7 | QDELQuidelOrtho Corporation Common Stock | $909M | 7Weak |
| 8 | CDIOCardio Diagnostics Holdings Inc. Common stock | $5M | 0Weak |
| 9 | CLDXCelldex Therapeutics, Inc | $2.4B | 0Weak |
| 10 | TRIBTrinity Biotech plc | $5M | 0Weak |
| 11 | NTLAIntellia Therapeutics, Inc | $1.7B | 0Weak |
| 12 | VNRXVolitionRx Limited | $6M | 0Weak |
| 13 | VRAXVirax Biolabs Group Limited Ordinary Shares | $964355 | 0Weak |
Track in vitro & in vivo diagnostic substances quality
Follow these names, get weekly AI research digests, and see when their scores change.
Start free